If the Bavi control arm got opdivo how can anyone take this phase III study seriously? If the FDA was truly a fair and impartial agency they would not have allowed that. Was this in the trial design? At the very least Bavi+ chemo should be compared to a clean chemo trial like the opdivo control arm.